Neuromodulators: Difference between revisions
From Proteopedia
Jump to navigationJump to search
New page: <StructureSection load='' size='350' side='right' scene='47/475982/Cv/1' caption='Structure of the human dopamine D3 receptor in complex with the antagonist eticlopride and maltose, [[3pbl... |
No edit summary |
||
| Line 1: | Line 1: | ||
<StructureSection load='' size='350' side='right' scene='47/475982/Cv/1' caption='Structure of the human dopamine D3 receptor in complex with the antagonist eticlopride and maltose, [[3pbl]]'> | <StructureSection load='' size='350' side='right' scene='47/475982/Cv/1' caption='Structure of the human dopamine D3 receptor in complex with the antagonist eticlopride and maltose, [[3pbl]]'> | ||
A neuromodulator can be conceptualized as a [[neurotransmitter]] that is not reabsorbed by the pre-synaptic neuron or broken down into a metabolite. | |||
</StructureSection> | </StructureSection> | ||
== References == | == References == | ||
<references/> | <references/> | ||
Revision as of 11:54, 2 January 2022
| ||||||||||||